Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

After 12 weeks of treatment, the 4 mg and 6 mg mazdutide groups achieved reductions in BMI from baseline of 8.78% and 10.99%, respectively, with ...

This application is based on the encouraging results from the Phase 3 registration clinical study GLORY-2 (NCT06164873) of mazdutide 9 mg in Chinese adults with moderate to severe obesity. The study ...

A new study published in npj Aging provides compelling evidence that untreated obstructive sleep apnea (OSA) accelerates ...

Parkinson's disease affects more than 1.1 million people in the U.S. Early treatment of obstructive sleep apnea -- a condition that causes breathing to briefly pause -- may decrease the risk of ...

Obstructive sleep apnea and atrial fibrillation (AFib) are two conditions that share a potentially deadly link. Having one ...

That’s according to a new study led by Oregon Health & Science University and the Portland Veterans Affairs Health Care System, where researchers found that veterans with untreated obstructive sleep ...

Magnesium is touted as a sleep cure-all, but for apnea patients, the reality is nuanced, so let's analyze where it fits.

A major new study has found a notable connection between untreated sleep apnea and an increased risk of Parkinson’s disease. A team of researchers from Oregon Health and Science University (OHSU) ...

A massive veteran study found a strong connection between untreated sleep apnea and a higher chance of Parkinson’s. CPAP users had much lower odds of developing the condition. Researchers believe that ...

Continuous positive airway pressure (CPAP) termination rates among patients with OSA are affected by geographic disparities.

Add one more malady to the potential risks from untreated sleep apnea: Parkinson's disease. A new study involving 11 million U.S. veterans finds that a person's odds of developing Parkinson's nearly ...